Effects of PcTx1 and mambalgin-1 on ASIC1a homomeric and heteromeric channels. by Magda Chafaï (15307098)

<i>L</i>. <i>interrogans</i> requires both PerRA and PerRB for renal colonization of C3H/HeJ mice. by André A. Grassmann (11141592)

mCSM-PPI2 predicted ΔΔG with and without recalibration are in agreement with published deep mutagenesis binding data [22] at low predicted ΔΔG but recalibrated predictions are more... by Stuart A. MacGowan (11326845)

Sodium butyrate alleviates potential Alzheimer’s disease in vitro by suppressing Aβ and tau activation and ameliorates Aβ-induced toxicity by Al Borhan Bayazid (16711360)

“…We have investigated the neuroprotective effects of NaB in SH-SY5Y cells stimulated with TNF-α/Aβ in SH-SY5Y cells and LPS-induced BV-2 cells. …”

Presentation_1.PDF by Suborno Jati (5073956)

“…We found that during the initial hours of infection with PA and SP, there is decrease in the steady state levels of the Wnt5A protein in macrophages. …”

HDAC and proteasome inhibition leads to apoptosis via pro-apoptosis protein activation, ROS production and caspase activation. by Aimée N. Laporte (3617987)

“…(D) The low-dose quisinostat/bortezomib drug combination brings about a significant decrease in the viability of primary synovial sarcoma cells (83-SS) as compared to matched normal muscle cells derived from the same patient (83-muscle). …”

A Hierarchical Contact–Electrification Interface Based on Gradient Micro-/Nanostructured Hydrogel for Cardiovascular Disease Monitoring by Zhenqiu Gao (2564362)

“…Importantly, a preliminary 10 day blood pressure test on 22 volunteers showed an error margin of less than ±5 mm Hg, demonstrating its potential as a cardiovascular health product.…”

A Hierarchical Contact–Electrification Interface Based on Gradient Micro-/Nanostructured Hydrogel for Cardiovascular Disease Monitoring by Zhenqiu Gao (2564362)

“…Importantly, a preliminary 10 day blood pressure test on 22 volunteers showed an error margin of less than ±5 mm Hg, demonstrating its potential as a cardiovascular health product.…”

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Apoptotic gene expression induced by propofol. by Yali Ge (417371)

Subjects:

The details of terminal deoxynulceotidyl transferase nick-end-labeling (TUNEL) staining. by Yali Ge (417371)

Subjects:

Result of terminal deoxynulceotidyl transferase nick-end-labeling (TUNEL) staining. by Yali Ge (417371)

Subjects:

Result of whole-mount <i>in situ</i> hybridization at 48 hpf. by Yali Ge (417371)

Subjects:

Apoptotic gene expression without significant changes induced by propofol. by Yali Ge (417371)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Developmental toxicity induced by 2 μg/ml propofol. by Yali Ge (417371)

Subjects:

Effects of anesthesia on zebrafish locomotion (n = 28). by Yali Ge (417371)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Hatchability and heart rate between two groups. by Yali Ge (417371)

Subjects: